Pear Therapeutics

Product Pipeline

Product/
Candidate
Therapeutic
Area
Discovery and
Translation
POC Pivotal Commercial Content
Partner
Development
Partner
reSET Substance Use Disorder

Dartmouth
reSET-O Opioid Use Disorder

Dartmouth
Somryst* Insomnia/Depression

University of Virginia
PEAR-004* Schizophrenia

Novartis
DISCOVERY* IBS

Karolinska Institutet**
DISCOVERY* Pain

Firsthand Technology
DISCOVERY* PTSD

USC
DISCOVERY* Migraine

Cincinnati Children's
DISCOVERY* Bipolar Disorder

PEAR-006* Multiple Sclerosis

Novartis
DISCOVERY* Epilepsy

DISCOVERY* Specialty GI

Ironwood***
DISCOVERY* Oncology

Apricity Health
PLATFORM Voice Analytics

NeuroLex Winterlight

INTERNAL PARTNERED

* FDA has not determined the safety or effectiveness of this product candidate.
** Licensed content from individual researchers employed by the Karolinska Institute.
*** Pear entered into a services agreement with Ironwood to evaluate a PDT in GI diseases.